Intravenous (IV) Solutions

World Market Report

MCP22111

EXECUTIVE ENGAGEMENTS

POOL

1242
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

223
Interactions with Platform & by Email

PARTICIPANTS

52
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

67
Responses Validated*
* Login for a full stack data experience

DATE

JUL 2022

TABLES

210

PAGES

423

EDITION

9

PRICE

USD 5600

CODE

MCP22111


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

STRONG ACTIVE NICHE TRIVIAL

%

VALIDATED RESEARCH *

S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T
S A N T

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year


Global Intravenous (IV) Solutions Market to Reach US$15 Billion by the Year 2026

Intravenous solutions are nutrients such as amino acids, vitamins & minerals, carbohydrates, and parenteral lipid emulsion among others, which are delivered intravenously to the patient. Intravenous feeding of nutrients involves administration of nutritional supplements to the body through vein. Intravenous therapy is generally administered to patients with a non-functional gastrointestinal tract or those unable to consume nutrition through the oral route. An aging population, rising prevalence of chronic diseases, and the need to address nutritional needs of such patients are fueling growth in IV solutions market. Since the geriatric population is more likely to experience deficiency of various essential nutrients, intravenous therapy is often used to provide the necessary nutrition in this population. Growing number of preterm births is another factor driving market growth. Increasing number of pediatric GI disorders is also likely to foster demand for infant IV nutrition going forward. Another factor fueling growth in the IV solutions market is the growing threat of malnutrition particularly in low- and mid-income nations. The market is anticipated to generate increased revenue due to the IV infusions` rising positive clinical trials, which are propelling the vitamin C IV therapy`s adoption to treat cancer.

Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$11.2 Billion in the year 2022, is projected to reach a revised size of US$15 Billion by 2026, growing at a CAGR of 6.8% over the analysis period. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to grow at a 7.1% CAGR to reach US$11 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period. This segment currently accounts for a 32.8% share of the global Intravenous (IV) Solutions market. Total parenteral nutrition (TPN) is an approach that involves intravenous infusion of carefully balanced blend of minerals and vitamins. The treatment is administered in life-threatening scenarios such as intestinal failure, where a patient is unable to digest and absorb essential nutrients including minerals and vitamins required for survival. Furthermore, the TPN market is estimated to develop rapidly because of the increased significance in treating inflammatory bowel diseases such as Crohn`s and ulcerative colitis disease. Peripheral Parenteral Nutrition (PPN) is a short-term therapy that is provided only until enteral or central venous access is obtained or in the form of supplement to oral intake.

The U.S. Market is Estimated at $4.3 Billion in 2022, While China is Forecast to Reach $1.4 Billion by 2026

The Intravenous (IV) Solutions market in the U.S. is estimated at US$4.3 Billion in the year 2022. The country currently accounts for a 38.86% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$684.3 Million by the end of the analysis period. A growing elderly population with greater susceptibility to chronic illnesses is driving need for IV solutions in developed economies. Advent of novel IV solutions to meet the nutritional needs of pediatric patients, and growing awareness about the benefits of IV nutrition therapy for patients suffering from severe malnutrition are presenting favorable growth opportunities in developed economies. The high prevalence of malnourishment among children and high instances of malnutrition among expectant mothers, due to the large number of low- and mid-income nations in the regions, are driving demand for IV solutions. To deal with the issue, global organizations such as the UN and regional governments are undertaking aggressive awareness programs to reduce mortality rates, which is encouraging greater adoption of IV and PN solutions in healthcare settings.

The ability to produce high quality intravenous solutions is limited only to a few nations. This is specifically true for products that require administration using a pump. Consequently, products are mass-produced at few global locations, and are thereafter shipped to the point of use. Consequently, transportation cost accounts for a significant proportion of the overall costs, and contributes to increasing the overall price of the product/solution. In view of the limited production centers of intravenous solutions, several countries are compelled to rely on highly expensive imported products. Such products often remain out of bounds for the general populace. Though few countries have undertaken local production activities, the quality and high cost of products continues to pose challenges. Unavailability of low-cost and easily available IV solution supplies in several developing countries is leading to high mortality rates due to non-terminal illnesses. Hence, there exists a need for inexpensive yet high-quality IV solution supplies. In emerging markets, production of IV solutions generally involves limited investments, which in turn restricts the overall return on investments. In general, the production costs associated with the development of IV solutions are about 50-60% less in comparison to the market price of key product lines, specifically in developed countries such as the US. On the other hand, developing countries are characterized by lower labor costs, although the price of IV solutions remains considerably high.

SELECT PLAYERS

Amanta Healthcare; Anhui Medipharm Co., LTD.; Axa Parenterals Ltd.; B. Braun Melsungen Ag; Baxter International Inc.; Fresenius Kabi AG; Grifols, S.A.; ICU Medical, Inc.; JW Life Science; Otsuka Pharmaceutical Co. Ltd.; Pfizer Inc.; Salius Pharma Private Limited.; Vifor Pharma Management Ltd.

SEGMENTS

» Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition) » Nutrient (Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion, Other Nutrients)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
Pandemic Affects Demand for Intravenous Solutions
Elective Surgeries Report Roller-Coaster Ride Amid COVID-19, Affecting Demand for IV Solutions
EXHIBIT: COVID-19 Induced YOY Decline in Heart Surgery Volumes in the US in 2020
COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
Intravenous (IV) Solutions – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
An Introduction to Intravenous (IV) Solutions
Types of Intravenous Solutions
Global Market Prospects & Outlook
TPN Emerges as the Largest Segment in the IV Solutions Market
Single Dose Amino Acid Solutions: The Major Nutrient Type
Developed Economies Lead, Developing Regions to Propel Future Growth
Competition
World Brands
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
EXHIBIT: Daily Requirements for Adults (Male and Female) by Nutrient Type
EXHIBIT: Energy Requirements by Age and Gender
Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
Rising Cancer Incidence and Need for Nutritional Support
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2020
Alarming Rise in Diabetes Incidence Worldwide
EXHIBIT: World Diabetes and Population Statistics (2019, 2030 & 2045)
EXHIBIT: World Diabetes Prevalence (2000-2045)
EXHIBIT: Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
EXHIBIT: Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Unrelenting Threat of HIV/AIDS Infection
EXHIBIT: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
EXHIBIT: Number of AIDS-Related Deaths (in Thousands) by Region for 2018
Nutritional Management of Patients with Neurological Diseases
EXHIBIT: Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
Growing Numbers of Pre-term Births Drives Demand for IV Solutions
EXHIBIT: Top Countries Ranked by Most Number of Preterm Births
EXHIBIT: Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
Demand Rises for Home Intravenous Nutritional Therapies
Premixed IV Nutrition: A Step towards Safer Medication Practices
Premixed Formulations Present Efficient Delivery System
Iron Replacement Therapies: Potential for Growth
Growing Demand for Low-Cost Intravenous Nutrition Solutions
COVID-19 Outbreak: Combating Medication Errors in IV Infusion
Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
EXHIBIT: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Healthcare Expenditure Creates Conducive Environment
EXHIBIT: World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
Challenges Confronting IV Solutions Market
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Intravenous (IV) Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Total Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Total Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Total Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Peripheral Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Peripheral Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Single Dose Amino Acids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Single Dose Amino Acids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Vitamins & Minerals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vitamins & Minerals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Carbohydrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Carbohydrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Parenteral Lipid Emulsion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Parenteral Lipid Emulsion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Nutrients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Nutrients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
JAPAN
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
CHINA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
EUROPE
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Intravenous (IV) Solutions by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
FRANCE
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
GERMANY
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
UNITED KINGDOM
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intravenous (IV) Solutions by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
AUSTRALIA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Australia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
INDIA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
India Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
SOUTH KOREA
South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
LATIN AMERICA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intravenous (IV) Solutions by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ARGENTINA
Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
BRAZIL
Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
MEXICO
Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF LATIN AMERICA
Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
MIDDLE EAST
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intravenous (IV) Solutions by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Intravenous (IV) Solutions by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
IRAN
Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Iran Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
ISRAEL
Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Israel Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
SAUDI ARABIA
Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
UNITED ARAB EMIRATES
UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
UAE Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
REST OF MIDDLE EAST
Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
AFRICA
Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Intravenous (IV) Solutions by Type - Total Parenteral Nutrition and Peripheral Parenteral Nutrition Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Intravenous (IV) Solutions by Type - Percentage Breakdown of Value Sales for Total Parenteral Nutrition and Peripheral Parenteral Nutrition for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Intravenous (IV) Solutions by Nutrient - Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Intravenous (IV) Solutions by Nutrient - Percentage Breakdown of Value Sales for Single Dose Amino Acids, Vitamins & Minerals, Carbohydrates, Parenteral Lipid Emulsion and Other Nutrients for the Years 2012, 2021 & 2027
Total Companies Profiled: 67

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com